Vitateq Biotechnology

Austria
Innsbruck, Tyrol, Austria, 6020

Company profile

Vitateq Biotechnology company profile

Vitateq Biotechnology GmbH, founded in 2000, is a research-driven biotechnology spin-off from the Medical University of Innsbruck. Their research centers around the function of the vitamin E-binding protein AFAMIN and explores the very promising diagnostic and therapeutic applications of this biomarker in cancer, infertility, pregnancy complications, metabolic, cardiovascular and neurodegenerative diseases.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Founded
2000-01-01, Year

Headquarters

Postal code
6020
Country code
AT
Continent
Europe

Capital profile

Funding and company signals

No public funding data is available for this company.

Founders and investors

No public relation records are available.